Results 191 to 200 of about 23,474 (233)
Drug Intelligence & Clinical Pharmacy, 1984 Bupropion is a trimethylated monocyclic phenylaminoketone that is an effective antidepressant in humans. It neither is sedating, anticholinergic, nor cardiotoxic. Its mechanism of action may be related to dopamine, but remains uncertain at this time. Clinical trials comparing bupropion 300–750 mg/d with placebo show it to be superior ...
Dufresne, R., Weber, S., Becker, R. E.
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
, 2016 Bupropion hydrochloride is a norepinephrine-dopamine disinhibitor (NDDI) approved for the treatment of depression and smoking cessation. Bupropion is a trimethylated monocyclic phenylaminoketone second-generation antidepressant, which differs structurally from most antidepressants, and resides in a novel mechanistic class that has no direct action on ...
S R, Khan +6 more
openaire +4 more sources
Bupropion and Bupropion Analogs as Treatments for CNS Disorders
2014Bupropion, introduced as an antidepressant in the 1980s, is also effective as a smoking cessation aid and is beneficial in the treatment of methamphetamine addiction, cocaine dependence, addictive behaviors such as pathological gambling, and attention deficit hyperactivity disorder. (2S,3S)-hydroxybupropion is an active metabolite of bupropion produced
F Ivy, Carroll +5 more
openaire +2 more sources